Dongwha Pharm.Co.,Ltd
Research Dongwha Pharm.Co.,Ltd (000020.KS) on Bullrun: market cap KRW 153.00B, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker000020.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 153.00B
- Dividend yield1.2%
- Financial periodQ2 2026
- RevenueKRW 136.93B
- Net incomeKRW 6.65B
- Free cash flowKRW 15.38B
- Gross margin43.3%
Valuation Snapshot
latest market cap is KRW 153.00B; dividend yield is 1.2%.
Peer valuation comparison
Latest dividend yield is 1.18% versus a Healthcare sector median of 2.4% (50.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 153.00B | n/a | 1.2% | 65 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 65 KRW, yield 1.2%.
About Dongwha Pharm.Co.,Ltd
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dongwha Pharm.Co.,Ltd's market cap?
Dongwha Pharm.Co.,Ltd's market capitalization is KRW 153.00B.
Does Dongwha Pharm.Co.,Ltd pay a dividend?
Dongwha Pharm.Co.,Ltd has a dividend yield of 1.2%.
What does Dongwha Pharm.Co.,Ltd do?
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics.